Three U.S. sites in January began recruiting patients to test the safety and efficacy of an intravascular MRI catheter that preclinically differentiates the lipid-rich core of vulnerable plaque from other components.
Three U.S. sites in January began recruiting patients to test the safety and efficacy of an intravascular MRI catheter that preclinically differentiates the lipid-rich core of vulnerable plaque from other components. If proven effective, the technique could dramatically change treatment options for patients with coronary artery disease, according to principal investigator Dr. Ron Waksman, associate chief of cardiology at Washington Hospital Center in Washington, DC.
The objective of TOP-IMAGE II, which intends to enroll 100 subjects, is to assess the safety and functional performance of the device in patients whose plaques are not associated with high-grade stenosis.
Waksman, who spoke at the 2007 International Symposium on Endovascular Therapy, said intravascular ultrasound cannot visualize vulnerable plaques' fibrous cap and is only 37% sensitive for detecting plaque rupture. TopSpin Medical of Israel makes the IntraVascular MRI catheter.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.